Long-term survival of a woman with well differentiated papillary mesothelioma of the peritoneum: a case report and review of the literature

por Clarke, Jeffrey M, Helft, Paul
Publicado 2010

Keynote 42: Pembrolizumab, PD-L1, and where to draw the line

por Isaacs, James, Clarke, Jeffrey, Ready, Neal
Publicado 2020

Fgf signaling controls the telencephalic distribution of Fgf-expressing progenitors generated in the rostral patterning center

por Hoch, Renée V, Clarke, Jeffrey A, Rubenstein, John LR
Publicado 2015

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases

por Bedoya, Armando, Glisinski, Kristen, Clarke, Jeffrey, Lind, Richard N., Buckley, Charles Edward, Shofer, Scott
Publicado 2017

Changing the landscape of non-small cell lung cancer disparities

por Odera, Joab O., Abo, Muthana Al, Patierno, Steven R., Clarke, Jeffrey M., Freedman, Jennifer A.
Publicado 2021

Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis

por Dorry, Michael, Davidson, Kevin, Dash, Rajesh, Jug, Rachel, Clarke, Jeffrey M., Nixon, Andrew B., Mahmood, Kamran
Publicado 2021

Leptomeningeal disease: current diagnostic and therapeutic strategies

por Nayar, Gautam, Ejikeme, Tiffany, Chongsathidkiet, Pakawat, Elsamadicy, Aladine A., Blackwell, Kimberly L., Clarke, Jeffrey M., Lad, Shivanand P., Fecci, Peter E.
Publicado 2017

TRLS-10. MITIGATING NEUROCOGNITIVE DEFICITS FROM WHOLE-BRAIN RADIOTHERAPY IN PATIENTS WITH NUMEROUS BRAIN METASTASES VIA A NOVEL SUPEROXIDE DISMUTASE MIMETIC: RATIONALE & DESIGN OF...

por Kirkpatrick, John, Franklin, Heather, Torok, Jordan, Floyd, Scott, Anders, Carey, Fecci, Peter, Salama, April, Clarke, Jeffrey, George, Daniel, Crapo, James, Peters, Katherine
Publicado 2019

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer

por Chodavadia, Parth A., Jacobs, Corbin D., Wang, Frances, Salama, Joseph K., Kelsey, Chris R., Clarke, Jeffrey M., Ready, Neal E., Torok, Jordan A.
Publicado 2021

Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database

por Gupta, Anjali, Omeogu, Chioma, Islam, Jessica Y., Joshi, Ashwini, Zhang, Dongyu, Braithwaite, Dejana, Karanth, Shama D., Tailor, Tina D., Clarke, Jeffrey M., Akinyemiju, Tomi
Publicado 2023

Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial

por Le, Xiuning, Cornelissen, Robin, Garassino, Marina, Clarke, Jeffrey M., Tchekmedyian, Nishan, Goldman, Jonathan W., Leu, Szu-Yun, Bhat, Gajanan, Lebel, Francois, Heymach, John V., Socinski, Mark A.
Publicado 2022

Accuracy and clinical relevance of an automated, algorithm‐based analysis of facial signs from selfie images of women in the United States of various ages, ancestries and phototype...

por Flament, Frederic, Jiang, Ruowei, Houghton, Jeff, Zhang, Yuze, Kroely, Camille, Jablonski, Nina G., Jean, Aurelie, Clarke, Jeffrey, Steeg, Jason, Sehgal, Cassidy, McParland, James, Delaunay, Caroline, Passeron, Thierry
Publicado 2022

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

por Clarke, Jeffrey M., Gu, Lin, Wang, Xiaofei F., Stinchcombe, Thomas E., Stevenson, Marvaretta M., Ramalingam, Sundhar, Shariff, Afreen, Garst, Jennifer, Nixon, Andrew B., Antonia, Scott J., Crawford, Jeffrey, Ready, Neal E.
Publicado 2022

MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY

por Vaios, Eugene, Shenker, Rachel, Hendrickson, Peter, D’Anna, Rachel, Niedzwiecki, Donna, Carpenter, David, Floyd, Warren, Winter, Sebastian, Dietrich, Jorg, Floyd, Scott, Kirkpatrick, John, Mullikin, Trey, Allen, Karen, Salama, April, Clarke, Jeffrey, Reitman, Zachary
Publicado 2022

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

por Clarke, Jeffrey Melson, Blobe, Gerard C., Strickler, John H., Uronis, Hope Elizabeth, Zafar, S. Yousuf, Morse, Michael, Dropkin, Evan, Howard, Leigh, O’Neill, Margot, Rushing, Christel N., Niedzwiecki, Donna, Watson, Hollie, Bolch, Emily, Arrowood, Christy, Liu, Yingmiao, Nixon, Andrew B., Hurwitz, Herbert I.
Publicado 2019

A Need for More Molecular Profiling in Brain Metastases

por Shen, Erica, Van Swearingen, Amanda E. D., Price, Meghan J., Bulsara, Ketan, Verhaak, Roeland G. W., Baëta, César, Painter, Brice D., Reitman, Zachary J., Salama, April K. S., Clarke, Jeffrey M., Anders, Carey K., Fecci, Peter E., Goodwin, C. Rory, Walsh, Kyle M.
Publicado 2022

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

por Rottey, Sylvie, Clarke, Jeffrey, Aung, Kyaw, Machiels, Jean-Pascal, Markman, Ben, Heinhuis, Kimberley M., Millward, Michael, Lolkema, Martijn, Patel, Sandip Pravin, de Souza, Paul, Duca, Matteo, Curigliano, Giuseppe, Santoro, Armando, Koyama, Takafumi, Brown, Michelle, Vezina, Heather, He, Chunsheng, Chu, Quincy Siu-Chung
Publicado 2022

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

por Conroy, Jeffrey M., Pabla, Sarabjot, Nesline, Mary K., Glenn, Sean T., Papanicolau-Sengos, Antonios, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L., Bshara, Wiam, Khalil, Maya, Dy, Grace K., Madden, Katherine G., Shirai, Keisuke, Dragnev, Konstantin, Tafe, Laura J., Zhu, Jason, Labriola, Matthew, Marin, Daniele, McCall, Shannon J., Clarke, Jeffrey, George, Daniel J., Zhang, Tian, Zibelman, Matthew, Ghatalia, Pooja, Araujo-Fernandez, Isabel, de la Cruz-Merino, Luis, Singavi, Arun, George, Ben, MacKinnon, Alexander C., Thompson, Jonathan, Singh, Rajbir, Jacob, Robin, Kasuganti, Deepa, Shah, Neel, Day, Roger, Galluzzi, Lorenzo, Gardner, Mark, Morrison, Carl
Publicado 2019

Autologous T cell therapy for MAGE-A4(+) solid cancers in HLA-A*02(+) patients: a phase 1 trial

por Hong, David S., Van Tine, Brian A., Biswas, Swethajit, McAlpine, Cheryl, Johnson, Melissa L., Olszanski, Anthony J., Clarke, Jeffrey M., Araujo, Dejka, Blumenschein, George R., Kebriaei, Partow, Lin, Quan, Tipping, Alex J., Sanderson, Joseph P., Wang, Ruoxi, Trivedi, Trupti, Annareddy, Thejo, Bai, Jane, Rafail, Stavros, Sun, Amy, Fernandes, Lilliam, Navenot, Jean-Marc, Bushman, Frederic D., Everett, John K., Karadeniz, Derin, Broad, Robyn, Isabelle, Martin, Naidoo, Revashnee, Bath, Natalie, Betts, Gareth, Wolchinsky, Zohar, Batrakou, Dzmitry G., Van Winkle, Erin, Elefant, Erica, Ghobadi, Armin, Cashen, Amanda, Grand’Maison, Anne, McCarthy, Philip, Fracasso, Paula M., Norry, Elliot, Williams, Dennis, Druta, Mihaela, Liebner, David A., Odunsi, Kunle, Butler, Marcus O.
Publicado 2023